dronabinol has been researched along with Cramp in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chisari, CG; Fernández, Ó; Ferrer-Picón, E; Hernández Vicente, F; Patti, F; Sarroca, J; Vila Silván, C | 1 |
| Goldman, B; Truniger, S; Weber, M | 1 |
1 trial(s) available for dronabinol and Cramp
| Article | Year |
|---|---|
Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Appetite; Cross-Over Studies; Depression; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Muscle Cramp; Quality of Life; Severity of Illness Index; Sleep Wake Disorders | 2010 |
1 other study(ies) available for dronabinol and Cramp
| Article | Year |
|---|---|
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome'.
Topics: Cannabidiol; Central Nervous System Diseases; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Cramp; Muscle Spasticity; Pain; Spasm; Treatment Outcome | 2022 |